資料集
搜尋結果
-
A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study
Chiu, Y. (Contributor), Tang, C. (Contributor), Hung, S. (Contributor), Yang, Y. (Contributor), Fang, C. (Contributor) & Lin, H. (Contributor), Unknown Publisher, 5月 4 2017
DOI: 10.6084/m9.figshare.4047471.v1, https://tandf.figshare.com/articles/journal_contribution/A_real-world_risk_analysis_of_biological_treatment_adalimumab_and_etanercept_in_a_country_with_a_high_prevalence_of_tuberculosis_and_chronic_liver_disease_a_nationwide_population-based_study/4047471/1
資料集: Dataset
-
Factors affecting discontinuation of adalimumab and etanercept therapy in anti-TNF-naïve patients with ankylosing spondylitis: Nationwide population-based cohort study
Chen, H. (Contributor), Chen, Y. (Contributor), Lai, K. (Contributor), Lin, C. (Contributor), Tang, C. (Contributor) & Chen, D. (Contributor), Unknown Publisher, 9月 8 2015
DOI: 10.6084/m9.figshare.1601856.v1, https://tandf.figshare.com/articles/journal_contribution/Factors_affecting_discontinuation_of_adalimumab_and_etanercept_therapy_in_anti_TNF_na_239_ve_patients_with_ankylosing_spondylitis_Nationwide_population_based_cohort_study/1601856/1
資料集: Dataset
-
Protein-energy wasting significantly increases healthcare utilization and costs among patients with chronic kidney disease: a propensity-score matched cohort study
Chao, C. (Contributor), Tang, C. (Contributor), Cheng, R. W. (Contributor), Wang, M. Y. (Contributor) & Hung, K. (Contributor), Unknown Publisher, 9月 2 2017
DOI: 10.6084/m9.figshare.5198317.v1, https://tandf.figshare.com/articles/figure/Protein-energy_wasting_significantly_increases_healthcare_utilization_and_costs_among_patients_with_chronic_kidney_disease_a_propensity-score_matched_cohort_study/5198317/1
資料集: Dataset